BSECompany Update5d ago · 14 Aug 2026, 08:35 pm

We hereby inform the appointment of Mr. Namit Soni (DIN- 02910984) as an Additional Executive Director w.e.f 14th August 2026.

Soni Medicare Ltd · 539378

✦ AI SummaryMgmt Change

Soni Medicare Ltd has appointed Mr. Namit Soni as an Additional Executive Director with effect from August 14, 2026, who will hold office up to the next Annual General Meeting.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Soni Medicare Ltd - 539378 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

56c8ce25-86f4-4657-938a-4a341150ef26.pdf

pdf

Download →
View document text
SONI MEDICARE LIMITED 38, Kanota Bagh, Jawahar Lal Nehru Marg, JAIPUR-302 004 INDIA CIN No: - L51397RJ1988PLC004569 Telephone: (0141) 5163700, Fax: (0141) 2564392 E-mail: sonihospital@sonihospitals.com Date: 14th August, 2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai- 400001 Sub: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Ref: Scrip Code: 539378 Security Id: SML Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board at its meeting held on Friday, 14th August 2026, the Board has appointed Mr. Namit Soni (DIN: - 02910984) as Additional Executive Director w.e.f. 14th August 2026 who shall hold office up to the date of next Annual General Meeting of the Company. Disclosure required to be made in terms of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is as under: - You are requested to kindly take above information on your records. Thanking You Yours Faithfully For SONI MEDICARE LIMITED CIN: L51397RJ1988PLC004569 HARI KRISHAN TIWARI (Company Secretary and Compliance Officer) Membership No: FCS-5242 SONI MEDICARE LIMITED 38, Kanota Bagh, Jawahar Lal Nehru Marg, JAIPUR-302 004 INDIA CIN No: - L51397RJ1988PLC004569 Telephone: (0141) 5163700, Fax: (0141) 2564392 E-mail: sonihospital@sonihospitals.com Annexure A Disclosure required to be made in terms of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January, 2026 is as under: -: Sr. No Details of event that Information of Such Event(S) Needs to be provided 1 Reason for change -appointment, MR. NAMIT SONI has been appointed as Additional Executive Director of the Company, who shall hold office up to the date of next Annual General Meeting of the Company 2 Date of 14th August, 2026 Appointment 3 Term of appointment He will be liable to retire by Rotation. He shall hold office up to the date of next Annual General Meeting of the Company 4 Brief Profile (In case of MR. NAMIT SONI graduated from St. Stephens’ Appointment) College in 2008, and later completing his MBA in Marketing from IMI, New Delhi having strong expertise in healthcare administration, financial management, and strategic planning, committed to driving operational excellence and enhancing patient care delivery. 5 Disclosure of relationship between He is the son of the Chairman and MD Mr. Bimal Directors (in case of appointment of a Roy Soni and the Non-Executive Director Mrs. Director) Anju Soni. 6 Information as required pursuant to Mr. NAMIT SONI is not debarred from holding BSE Circular with ref. no. office of Directors by virtue of any order passed LIST/COMP/14/ 2018- 19 and the by Securities and Exchange Board of India or National Stock Exchange of India Ltd any other authority. with ref. no. NSE/CML/2018/24, dated 20th June, 2018